Literature DB >> 16395391

Mannose-binding lectin and its genetic variants.

P Garred1, F Larsen, J Seyfarth, R Fujita, H O Madsen.   

Abstract

Mannose-binding lectin (MBL) is a collagen-like serum protein that mediates activation of the complement system and is of importance for host defence. Common variant alleles situated both in the promoter and structural region of the human MBL gene (MBL2) influence the stability and the serum concentration of the protein. Epidemiological studies have suggested that genetically determined variation in MBL serum concentration influences the susceptibility to and the course of different types of infections, autoimmune, metabolic and cardiovascular diseases, but this is still a subject of debate. The fact that these genetic variations are very frequent indicates a dual role for MBL in host defence. In this survey, we summarize the current molecular understanding of human MBL genetics.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16395391     DOI: 10.1038/sj.gene.6364283

Source DB:  PubMed          Journal:  Genes Immun        ISSN: 1466-4879            Impact factor:   2.676


  130 in total

1.  Structural gene variants in the porcine mannose-binding lectin 1 (MBL1) gene are associated with low serum MBL-A concentrations.

Authors:  Helle R Juul-Madsen; Rikke M Kjærup; Charlotte Toft; Mark Henryon; Peter M H Heegaard; Peer Berg; Tina S Dalgaard
Journal:  Immunogenetics       Date:  2011-01-28       Impact factor: 2.846

2.  Mannose-binding lectin-the forgotten molecule?

Authors:  Michael Osthoff; George Trendelenburg; Damon P Eisen; Marten Trendelenburg
Journal:  Nat Med       Date:  2011-12-06       Impact factor: 53.440

3.  3'-UTR and functional secretor haplotypes in mannose-binding lectin 2 are associated with increased colon cancer risk in African Americans.

Authors:  Krista A Zanetti; Majda Haznadar; Judith A Welsh; Ana I Robles; Bríd M Ryan; Andrew C McClary; Elise D Bowman; Julie E Goodman; Toralf Bernig; Stephen J Chanock; Curtis C Harris
Journal:  Cancer Res       Date:  2012-01-26       Impact factor: 12.701

4.  Mannose-binding lectin and pulmonary morbidity in premature infants.

Authors:  Rachel S Agbeko; Mark J Peters
Journal:  Intensive Care Med       Date:  2008-01-24       Impact factor: 17.440

5.  Ficolin-2 binds to HIV-1 gp120 and blocks viral infection.

Authors:  Fengling Luo; Tielong Chen; Jun Liu; Xihui Shen; Yinnan Zhao; Rongge Yang; Xiaolian Zhang
Journal:  Virol Sin       Date:  2016-08-29       Impact factor: 4.327

6.  Collectin-11/MASP complex formation triggers activation of the lectin complement pathway--the fifth lectin pathway initiation complex.

Authors:  Ying Jie Ma; Mikkel-Ole Skjoedt; Peter Garred
Journal:  J Innate Immun       Date:  2012-12-04       Impact factor: 7.349

7.  Chicken mannose-binding lectin (MBL) gene variants with influence on MBL serum concentrations.

Authors:  Rikke M Kjærup; Liselotte R Norup; Karsten Skjødt; Tina S Dalgaard; Helle R Juul-Madsen
Journal:  Immunogenetics       Date:  2013-03-02       Impact factor: 2.846

8.  Childhood exposure to secondhand smoke and functional mannose binding lectin polymorphisms are associated with increased lung cancer risk.

Authors:  Susan E Olivo-Marston; Ping Yang; Leah E Mechanic; Elise D Bowman; Sharon R Pine; Christopher A Loffredo; Anthony J Alberg; Neil Caporaso; Peter G Shields; Stephen Chanock; Yanhong Wu; Ruoxiang Jiang; Julie Cunningham; Jin Jen; Curtis C Harris
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-12       Impact factor: 4.254

9.  Genetic variants of complement genes ficolin-2, mannose-binding lectin and complement factor H are associated with leprosy in Han Chinese from Southwest China.

Authors:  Deng-Feng Zhang; Xian-Qiong Huang; Dong Wang; Yu-Ye Li; Yong-Gang Yao
Journal:  Hum Genet       Date:  2013-02-20       Impact factor: 4.132

10.  A novel mannose-binding lectin/ficolin-associated protein is highly expressed in heart and skeletal muscle tissues and inhibits complement activation.

Authors:  Mikkel-Ole Skjoedt; Tina Hummelshoj; Yaseelan Palarasah; Christian Honore; Claus Koch; Karsten Skjodt; Peter Garred
Journal:  J Biol Chem       Date:  2010-01-06       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.